Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system
- PMID: 10805091
- DOI: 10.1007/s004010051150
Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system
Abstract
Pathological changes which consistently develop in the lower brain stem of patients suffering from Parkinson's disease are described against the background of the internal organization and interconnections of the involved nuclei, i.e., the gigantocellular reticular nucleus, bulbar raphe nuclei, and coeruleus-subcoeruleus area. Immunoreactions against the presynaptic protein alpha-synuclein reveal not only the voluminous forms of Lewy bodies and Lewy neurites but also the otherwise inconspicuous dot- or thread-like types. These lesions develop solely in specific neuronal types. Lipofuscin- or neuromelanin-laden projection cells which at the same time generate a long, unmyelinated or sparsely myelinated axon are particularly susceptible to developing the changes. The bulbar nuclei under consideration receive strong input from supramedullary sources, above all from higher order centers of the limbic system such as the central amygdalar nucleus, periaqueductal gray, and parabrachial nuclei. In turn, they generate descending projections to premotor and motor neurons of the somatomotor system. The disease-related deterioration of both the supramedullary limbic centers and the bulbar brain stem nuclei reduces the limbic influence and markedly impairs the control of premotor and motor neurons. This functional deficit most probably contributes to the overall dysfunction of the motor system typically evolving in the course of Parkinson's disease.
Similar articles
-
alpha-synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei.Acta Neuropathol. 2001 Mar;101(3):195-201. doi: 10.1007/s004010000247. Acta Neuropathol. 2001. PMID: 11307617
-
Where does parkinson disease pathology begin in the brain?J Neuropathol Exp Neurol. 2002 May;61(5):413-26. doi: 10.1093/jnen/61.5.413. J Neuropathol Exp Neurol. 2002. PMID: 12030260
-
Spinal cord lesions in sporadic Parkinson's disease.Acta Neuropathol. 2012 Nov;124(5):643-64. doi: 10.1007/s00401-012-1028-y. Epub 2012 Aug 29. Acta Neuropathol. 2012. PMID: 22926675
-
[Lewy bodies, a misleading marker for Parkinson's disease?].Bull Acad Natl Med. 2003;187(2):277-92; discussion 292-3. Bull Acad Natl Med. 2003. PMID: 14556441 Review. French.
-
Pathoanatomy of Parkinson's disease.J Neurol. 2000 Apr;247 Suppl 2:II3-10. doi: 10.1007/PL00007758. J Neurol. 2000. PMID: 10991663 Review.
Cited by
-
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia.PLoS One. 2012;7(11):e48783. doi: 10.1371/journal.pone.0048783. Epub 2012 Nov 8. PLoS One. 2012. PMID: 23144969 Free PMC article.
-
The pontine REM switch: past and present.J Physiol. 2007 Nov 1;584(Pt 3):735-41. doi: 10.1113/jphysiol.2007.140160. Epub 2007 Sep 20. J Physiol. 2007. PMID: 17884926 Free PMC article. Review.
-
Differential involvement of the periaqueductal gray in multiple system atrophy.Auton Neurosci. 2010 Dec 8;158(1-2):111-7. doi: 10.1016/j.autneu.2010.07.009. Epub 2010 Aug 21. Auton Neurosci. 2010. PMID: 20732833 Free PMC article.
-
The Microbiome as a Modifier of Neurodegenerative Disease Risk.Cell Host Microbe. 2020 Aug 12;28(2):201-222. doi: 10.1016/j.chom.2020.06.008. Cell Host Microbe. 2020. PMID: 32791113 Free PMC article. Review.
-
α-Synuclein pathology in Parkinson disease activates homeostatic NRF2 anti-oxidant response.Acta Neuropathol Commun. 2021 Jun 6;9(1):105. doi: 10.1186/s40478-021-01209-3. Acta Neuropathol Commun. 2021. PMID: 34092244 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous